Taysha Gene Therapies Inc (TSHA)
Stock-Based Compensation
$5.81M
Quarterly · Period ending: · USD
TSHA Stock-Based Compensation
Latest reported$5.81Mperiod ending
Latest reported$5.81Mperiod ending
TSHA Quarterly Stock-Based Comp ($0.00 → $5.81M)
Quarterly stock-based compensation
High-resolution chart · PNG
TSHA stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 5,810,000 | |
| 5,547,000 | |
| 3,529,000 | |
| 3,285,000 | |
| 3,190,000 | |
| 3,294,000 | |
| 3,216,000 | |
| 3,357,000 | |
| 3,332,000 | |
| 3,198,000 | |
| 1,968,000 | |
| 2,040,000 | |
| 2,222,000 | |
| 1,675,000 | |
| 4,103,000 | |
| 4,470,000 | |
| 4,141,000 | |
| 5,329,000 | |
| 4,955,000 | |
| 5,086,000 | |
| 4,549,000 | |
| 3,594,000 | |
| 2,013,000 | |
| 1,341,000 | |
| 0 | |
| 0 | |
| 0 |